DOI: https://doi.org/10.26641/2307-0404.2018.3(part1).142371

Arterial stiffness, ambulatory blood pressure monitoring and their association with cardiovascular risk in patients with chronic kidney disease and arterial hypertension.

V. V. Semenov

Abstract


The aim – to investigate arterial stiffness, daily profile of blood pressure (BP) and their association with cardiovascular risk (CVR) in patients with chronic kidney disease (CKD) and arterial hypertension (AH). 20 patients with CKD (stage 1-2) and AH (stage 1-2) were enrolled in the study (7 males and 13 females, mean age – 55±8,4 years. Depending on CVR risk patients were distributed into three groups: low (<1%), moderate (1-10%) and high risk (≥10%). The highest proportion – patients with moderate risk (50%). Statistically significant association between age and CVR was discovered. Arterial stiffness (measured by pulse pressure and pulse wave velocity) raised with increase of CVR risk. The best values of endothelial function were observed in the group of high risk patients. More than half of patients had non-dipping daily blood pressure profile. Patients in group of high risk presented the highest mean sysolic BP and morning elevation BP.

Keywords


cardiovascular risk; chronic kidney disease; arterial hypertension; arterial stiffness; endothelial function

References


[Blood pressure meter BAT41-2. The user's guide to determining the parameters of central aortic pressure and arterial stiffness]. Russian.

Kuryata OV, Garmish IP. [The level of protei­nuria and the state of endothelial function in patients with chronic kidney disease combined with subclinical hy­pothyroidism under the influence of combined antihyper­ten­sive therapy]. Medicni perspectivi. 2018;23(2 part 1):19-24. https://doi.org/10.26641/2307-0404.2018.2(part1).129510. Ukrainian.

Kuryata OV, Zabida A, Sirenko O. [Galectin-3, advanced glycated end-products serum levels, endothelial function and cardiac hemodynamics in post infarction heart failure patients with reduced and preserved ejection fraction]. Medicni perspectivi. 2018;23(2 part 1):69-74. https://doi.org/10.26641/2307-0404.2018.2(part1).129519

Wright JT, Jr, Williamson JD, Whelton PK et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103-16.

Jablonski KL, Decker E, Perrenoud L, et al. As­sessment of Vascular Function in Patients With Chronic Kid­ney Disease. J. Vis. Exp. (88), e51478, doi: 10.3791/51478

Barry LC, Elizabeth AC. Efficacy and Safety of Nighttime Dosing of Antihypertensives: Review of the Literature and Design of a Pragmatic Clinical Trial. J Clin Hypertens (Greenwich). 2014 February;16(2):115-21. doi: 10.1111/jch.12238.

Major RW, Cheng MRI, Grant RA. Cardio­vascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. PLoS One. 2018 Mar 21;13(3):e0192895. doi: 10.1371/journal.pone.0192895. ECollection 2018.

Centers for Disease Control and Prevention. Age-adjusted prevalence of CKD Stages 1-4 by Gender 1999-2012. Chronic Kidney Disease (CKD) Surveillance Pro­ject website. https://nccd.cdc.gov. Accessed December 6, 2016.

O’Brien E, Parati G, Stergiou G et al. European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring. Journal of Hypertension 2013, 31:1731-68. doi: 10.1097/HJH.0b013e328363e964

Perk J, De Backer G, Gohlke H et al. European Guidelines on cardiovascular disease prevention in cli­nical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other So­cieties on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). European Heart Journal. 2012;33:1635-701. doi: 10.1093/eurheartj/ehs092

Mansia G, De Backer G, Dominiczak A. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of ar­terial hypertension of the European Society of Hyper­tension (ESH) and of the European Society of Cardiology (ESC). Blood Press. 2007;16(3):135-232.

Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus do­cument on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588-605.

Julie HI, Kirsten LJ. Exclusion of Patients With Kid­ney Disease From Cardiovascular Trials. JAMA Intern Med. 2016;176(1):124-5. doi: 10.1001/jamainternmed.2015.6403

Judd E, Calhoun DA. Management of hyper­ten­sion in CKD: beyond the guidelines. Adv Chronic Kid­ney 2015 Mar;22(2):116-22. doi: 10.1053/j.ackd.2014.12.001

Greeve SV. Estimated Pulse Wave Velocity Cal­culated from Age and Mean Arterial Blood Pressure. Pulse (Basel). 2017 Jan;4(4):175-9. Published online 2016 Dec 1. doi: 10.1159/000453073

Csaba EK. Hypertension in chronic kidney di­sease after the Systolic Blood Pressure Intervention Trial: targets, treatment and current uncertainties. Nephrol Dial Transplant. 2017;32:ii219-23 doi: 10.1093/ndt/gfw269

Townsend RR, Wilkinson IB, Schiffrin EL, Avo­lio AP, Chirinos JA, Cockcroft JR, Heffernan KS, Lakatta EG, McEniery CM, Mitchell GF, Najjar SS, Nichols WW, Urbina EM, Weber T. Recommendations for im­proving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66:698-722.

Safar ME. Arterial stiffness as a risk factor for clinical hypertension. Nat Rev Cardiol. 2018 Feb;15(2):97-105. doi: 10.1038/nrcardio.2017.155. Epub 2017 Oct 12.

Townsend RR. Arterial Stiffness: Recommen­da­tions Standardization. Pulse (Basel). 2017 Jan;4(Suppl 1):3-7. doi: 10.1159/000448454

Manuel TV, Srinivasan B, Ehsan N. Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time? Kidney Int Rep. 2016 July;1(2):94-104. doi: 10.1016/j.ekir.2016.05.001


GOST Style Citations


  1. Измеритель артериального давления ВАТ 41-2. Руководство пользователю в части определения параметров центрального аортального давления и жесткости сосудов.
  2. Курята О.В. Рівень протеїнурії та стан ендо­теліальної функції судин у хворих на хронічну хво­робу нирок у поєднанні з субклінічним гіпотиреозом під впливом комбінованої антигіпертензивної терапії / О.В. Курята, І.П. Гарміш. // Медичні перспективи. – 2018. – №23. – С. 19–24.
  3. Курята О.В. Рівні галектину-3, продуктів кін­цевої глікації в сироватці крові, функціональний стан ендотелію та серцева гемодинаміка у хворих на серцеву недостатність після перенесеного інфаркту міокарда зі зниженою та збереженою фракцією ви­киду / О.В. Курята, А. Забіда, О.Ю. Сіренко. // Медич­ні перспективи. – 2018. – №23. – С. 69-74.
  4. A randomized trial of intensive versus standard blood-pressure control / J.T. Wright, J.D. Williamson, P.K. Whelton [et al.] // N. Engl. J. Med. – 2015. – Vol. 373. – P. 2103-2116.
  5. Assessment of Vascular Function in Patients With Chronic Kidney Disease / K.L. Jablonski, E. Decker, L. Per­renoud [et al.] // J Vis Exp. – 2014. – Vol. 88. – e51478.
  6. Barry L.C. Efficacy and Safety of Nighttime Do­sing of Antihypertensives: Review of the Literature and Design of a Pragmatic Clinical Trial / L.C. Barry, E.A. Chri­schilles // J. Clin. Hypertens (Greenwich). – 2014. – Vol. 16, N 2. – P. 115-121.
  7. Cardiovascular disease risk factors in chronic kid­ney disease: A systematic review and meta-analysis / R.W. Major, M.R.I. Cheng, R.A. Grant [et.al.] // PLoS One. – 2018. – Vol. 13, N 3. – e0192895.
  8. Centers for Disease Control and Prevention. Age-adjusted prevalence of CKD Stages 1-4 by Gender 1999-2012. Chronic Kidney Disease (CKD) [Електронний ресурс] / Centers for Disease Control and Prevention // Surveillance Project website. – 2016. – Режим доступу до ресурсу: https://nccd.cdc.gov.
  9. European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring / E. O’Brien, G. Parati, G. Stergiou [et al.] // J. Hypertension. – 2013. – Vol. 31. – P. 1731-1768.
  10. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) / J. Perk, G. De Backer, H. Gohlke [et al.] // Eur. Heart J. – 2012. – Vol. 33. – P. 1635-1701.
  11. ESH-ESC Guidelines for the management of ar­terial hypertension: the task force for the management of arterial hypertension of the European Society of Hy­pertension (ESH) and of the European Society of Cardio­logy (ESC) / G.Mansia, G. De Backer, A.Dominiczak [et al.] // Blood Press. – 2007. – Vol. 16, N 3. – P. 135-232.
  12. Expert consensus document on arterial stiffness: methodological issues and clinical applications / S. Lau­rent, J.Cockroft, L. Van Bortel [et al.] // Eur. Heart J. – 2006. – Vol. 27. – P. 2588-2605.
  13. Ishida J.H. Exclusion of Patients With Kidney Disease From Cardiovascular Trials / J.H. Ishida, K.L. Johansen // JAMA Intern Med. – 2016. – Vol. 176, N 1. – P.124-125.
  14. Judd E.  Management of hypertension in CKD: beyond the guidelines / E. Judd, D.A. Calhoun // Adv. Chronic. Kidney Dis. – 2015. – Vol. 2, N 22. – P. 116-122.
  15. Greeve S.V. Estimated Pulse Wave Velocity Cal­culated from Age and Mean Arterial Blood Pressure / S.V. Greeve // Pulse (Basel). – 2017. – Vol. 4, N 4. – P. 175-179.
  16. Kovesdy C.E. Hypertension in chronic kidney di­sease after the Systolic Blood Pressure Intervention Trial: targets, treatment and current uncertainties / C.E. Ko­vesdy // Nephrol. Dial. Transplant. – 2017. – Vol. 32. – P. 219-223.
  17. Recommendations for improving and standar­dizing vascular research on arterial stiffness: a scientific statement from the American Heart Association / R.R. Townsend, I.B. Wilkinson, E.L. Schiffrin [et al.] // Hypertension. – 2015. – Vol. 66. – P. 698-722.
  18. Safar M.E. Arterial stiffness as a risk factor for clinical hypertension / M.E.Safar // Nat. Rev. Cardiol. – 2018. – Vol. 15, N 2. – P. 97-105.
  19. Townsend R.R. Arterial Stiffness: Recommen­dations and Standardization / R.R.Townsend // Pulse. Basel. – 2017. – Vol. 4. – P. 3-7.
  20. Velasquez M.T. Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time? / M.T. Velasquez, S. Beddhu, E. Nobakht // Kidney Int. Rep. – 2016. – Vol. 1, N 2. – P. 94-104.